News
Recent technological advances have opened new possibilities for the efficient and sustainable synthesis of various valuable ...
A lab-designed molecule developed and extensively studied by scientists with Virginia Tech's Fralin Biomedical Research ...
Since the discovery of penicillin nearly a century ago, antimicrobial resistance (AMR) has become a stealthy, pervasive enemy ...
Livagen peptide, a short-chain molecule derived from thymic tissues, has garnered attention recently for its intriguing ...
Alongside its expansion into low-scale oligo synthesis, the company has rebranded its custom oligos to better target ...
In research models, B7-33 has been associated with reduced fibrotic markers and improved tissue architecture. These findings ...
Ongoing research aims to delineate its full spectrum of activity, optimal strategies, and the breadth of its implications.
Kahn is a particular fan of the peptides NAD+ and glutathione—which, she says, “work synergistically to help with energy, ...
As pressure to comply with stringent environmental regulations mounts, could green chemistry strategies provide the solution?
The partnership combines AKBA’s industry knowledge and product expertise with PeptiSystems’ next-generation synthesizers. Asahi Kasei Bioprocess America will supply PeptiSystems, located in Uppsala, ...
The partnership between Asahi Kasei Bioprocess America and PeptiSystems will extend globally across all relevant markets, such as drug- and contract manufacturing. Based on flow-through chemistry and ...
exclusive partnership aimed at delivering a streamlined process to the peptide manufacturing industry. This collaboration establishes AKBA as the exclusive OEM for peptide synthesis columns to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results